ArticleInternational journal of molecular sciences2026

αHSA-proIL-12: A Tumor-Conditional IL-12 Prodrug with Reduced Systemic Toxicity and Potent Antitumor Activity.

Xi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.